Xtant Medical

Quarterly Financials

Values in thousands 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Revenue
$27,937
$29,943
$27,873
$28,108
Gross Profit
16,307
18,582
17,302
17,137
EBITDA
-2,690
-1,835
-2,492
EBIT
-3,763
-2,833
-3,496
Net Income
-5,024
-3,861
-4,400
-4,303
Net Change In Cash
27,937
29,943
27,873
28,108
Free Cash Flow
-3,822
-5,652
-6,528
-1,278
Cash
6,596
5,379
4,624
5,715
Basic Shares
135,100
130,269
130,201
130,180

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$91,303
$57,969
$55,263
$53,337
Gross Profit
55,467
32,137
32,490
34,392
EBITDA
-6,984
-5,428
-2,513
1,328
EBIT
-10,158
-6,724
-3,854
-767
Net Income
660
-8,485
-5,844
-7,023
Net Change In Cash
91,303
57,969
55,263
53,337
Cost of Revenue
2,120
-2,896
Free Cash Flow
-10,971
-7,105
-1,676
-2,276
Cash
5,715
20,298
18,243
2,341
Basic Shares
126,793
94,085
85,456
28,499

Earnings Calls

Quarter EPS
2024-09-30
-$0.04
2024-06-30
-$0.03
2024-03-31
-$0.03
2023-12-31
-$0.03